The liabilities of Pharma Equity Group with headquarters in Denmark amounted to **** Danish kroner in 2024. The reported fiscal year ends on December 31.
Compared to 2020, this marks a decrease of approximately *** Danish kroner. The trend from 2020 to 2024 shows, however, that this decrease did not happen continuously.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Nasdaq Nordic. (December 11, 2025). Liabilities of Pharma Equity Group from 2020 to 2024 (in million Danish kroner) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 22, 2026, from /statistics/1594208/pharma-equity-group-liabilities/
Nasdaq Nordic. "Liabilities of Pharma Equity Group from 2020 to 2024 (in million Danish kroner)." Chart. December 11, 2025. ÌÇÐÄÆÆ½â°æ. Accessed July 22, 2026. /statistics/1594208/pharma-equity-group-liabilities/
Nasdaq Nordic. (2025). Liabilities of Pharma Equity Group from 2020 to 2024 (in million Danish kroner). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 22, 2026. /statistics/1594208/pharma-equity-group-liabilities/
Nasdaq Nordic. "Liabilities of Pharma Equity Group from 2020 to 2024 (in Million Danish Kroner)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 11 Dec 2025, /statistics/1594208/pharma-equity-group-liabilities/
Nasdaq Nordic, Liabilities of Pharma Equity Group from 2020 to 2024 (in million Danish kroner) ÌÇÐÄÆÆ½â°æ, /statistics/1594208/pharma-equity-group-liabilities/ (last visited July 22, 2026)
Liabilities of Pharma Equity Group from 2020 to 2024 (in million Danish kroner) [Graph], Nasdaq Nordic, December 11, 2025. [Online]. Available: /statistics/1594208/pharma-equity-group-liabilities/